"As the rich nations have gotten richer, they have also become fatter. As today's chart of the day shows, US tops the list for having the most obese population, while Indians in contrast are much leaner. The reasons are not hard to find. With incomes rising, lifestyles have also seen a perceptible change. And although India in comparison lags much behind, the incidence of cardiovascular diseases and diabetes has been increasing. Little wonder then, that if one looks at the product portfolio of pharmaceutical companies across the world including India, most of the revenue generating products would cater to the obesity related diseases. "
Basantji,
Our inclusion of Zydus in the TEDXI is very rational with a sugarfree product.
I do not know if I am asking the right question but what would be the entry cost and criteria to such a business by other players?
It should not become an intensely competitive business leaving none of the players in healthy profits flows.
~Supratik